AVIRAtea Pharmaceuticals, Inc.

Healthcare
$5.15+73% 1Y

The financials

Atea Pharmaceuticals, Inc. by the numbers

The next results filing is expected around Nov 11, 2026, the same week as a year ago.

Atea Pharmaceuticals, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$35M−$41Mn/a
Net income−$33M−$37Mn/a
Diluted EPS−$0.41−$0.44n/a

Biotechnology

Ranks #34 of 196 by RyuScore

Compare peers
YDES-0.94%
YD Bio Ltd
RGNX+6.5%
REGENXBIO Inc.
NGNE+2.3%
Neurogene Inc.
EIKN-0.66%
Eikon Therapeutics, Inc.
TECX-0.20%
Tectonic Therapeutic, Inc.
DMAC+0.38%
DiaMedica Therapeutics Inc.